Elucidation of the mechanism, target gene, and the most active parts of Fuzheng Yiliu formula in the treatment of hepatocellular carcinoma
Fuzheng Yiliu formula (FZYL) is a traditional Chinese medicine prescription in treating hepatocellular carcinoma (HCC) that can improve immunity and inhibit tumor, but its mechanism and molecular targets remain elusive. In this study, we seek to identify the active ingredients, the oral bioavailabil...
Main Authors: | Qingquan Bai, Tianhui Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Pharmacological Research - Modern Chinese Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667142522000781 |
Similar Items
-
Antitumor effect of IL-12 gene-modified bone marrow mesenchymal stem cells combined with Fuzheng Yiliu decoction in an in vivo glioma nude mouse model
by: Jianjun Wu, et al.
Published: (2021-04-01) -
Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
by: Zhang H, et al.
Published: (2022-09-01) -
Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
by: Yuqing Xie, et al.
Published: (2023-02-01) -
Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I–induced kidney fibrosis through network pharmacology
by: Fan Wang, et al.
Published: (2022-12-01) -
The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach
by: Xinrui Xing, et al.
Published: (2018-05-01)